References
- Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-2117. https://doi.org/10.1016/S0140-6736(05)67889-0
-
Wisniewski T. Is amyloid-
$\beta$ -peptide immunization clinically effective in patients with Alzheimer's disease? Nat Clin Pract Neurol 2005;1:84-85. https://doi.org/10.1038/ncpneuro0019 - Akhondzadeh S, Abbasi SH. Herbal medicine in the treatment of Alzheimer's disease. Am J Alzheimers Dis Other Demen 2006;21:113-118. https://doi.org/10.1177/153331750602100211
- Sorensen H, Sonne J. A double-masked study of the effects of ginseng on cognitive functions. Curr Ther Res 1996;57:959-968. https://doi.org/10.1016/S0011-393X(96)80114-7
- Scholey A, Ossoukhova A, Owen L, Ibarra A, Pipingas A, He K, Roller M, Stough C. Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology (Berl) 2010;212:345-356. https://doi.org/10.1007/s00213-010-1964-y
- Lee ST, Chu K, Sim JY, Heo JH, Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis Assoc Disord 2008;22:222-226. https://doi.org/10.1097/WAD.0b013e31816c92e6
- Heo JH, Lee ST, Chu K, Oh MJ, Park HJ, Shim JY, Kim M. An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease. Eur J Neurol 2008;15:865-868. https://doi.org/10.1111/j.1468-1331.2008.02157.x
- McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944. https://doi.org/10.1212/WNL.34.7.939
- Nam KY. The comparative understanding between red ginseng and white ginsengs, processed ginsengs (Panax ginseng C.A. Meyer). J Ginseng Res 2005;29:1-18. https://doi.org/10.5142/JGR.2005.29.1.001
- Burns A, Gauthier S, Perdomo C. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease. Int J Geriatr Psychiatry 2007;22:806-812. https://doi.org/10.1002/gps.1746
- Minthon L, Wallin AK, Eriksson S, Wattmo C, Andreasen N. Long-term rivastigmine treatment in a routine clinical setting. Acta Neurol Scand 2009;119:180-185.
- Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, Edwards S, Hardyman W, Raftery J, Crome P et al. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 2004;363:2105-2115. https://doi.org/10.1016/S0140-6736(04)16499-4
- Kanaya K, Abe S, Sakai M, Fujii H, Iwamoto T. Changes in cognitive functions of patients with dementia of the Alzheimer type following long-term administration of donepezil hydrochloride: relating to changes attributable to differences in apolipoprotein E phenotype. Geriatr Gerontol Int 2010;10:25-31. https://doi.org/10.1111/j.1447-0594.2009.00551.x
-
Liu L, Hoang-Gia T, Wu H, Lee MR, Gu L, Wang C, Yun BS, Wang Q, Ye S, Sung CK. Ginsenoside
$Rb_1$ improves spatial learning and memory by regulation of cell genesis in the hippocampal subregions of rats. Brain Res 2011;1382:147-154. https://doi.org/10.1016/j.brainres.2011.01.051 -
Zhao R, Zhang Z, Song Y, Wang D, Qi J, Wen S. Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3
$\beta$ pathway in ginsenoside$Rb_1$ 's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation. J Ethnopharmacol 2011;133:1109-1116. https://doi.org/10.1016/j.jep.2010.11.054 - Zhang JT, Liu Y, Qu ZW, Zhang XL, Xiao HL. Influence of ginsenoside Rb1 and Rg1 on some central neurotransmitter receptors and protein biosynthesis in the mouse brain. Yao Xue Xue Bao 1988;23:12-16.
- Ying Y, Zhang JT, Shi CZ, Qu ZW, Liu Y. Study on the nootropic mechanism of ginsenoside Rb1 and Rg1: influence on mouse brain development. Yao Xue Xue Bao 1994;29:241-245.
Cited by
- )-Rg3 vol.288, pp.29, 2013, https://doi.org/10.1074/jbc.M112.445734
- A Systematic Review on Natural Medicines for the Prevention and Treatment of Alzheimer's Disease with Meta-Analyses of Intervention Effect of Ginkgo vol.42, pp.03, 2014, https://doi.org/10.1142/S0192415X14500335
- Combination with Red ginseng and Polygoni Multiflori ameliorates highfructose diet induced metabolic syndrome vol.16, pp.1, 2016, https://doi.org/10.1186/s12906-016-1063-7
- Herbal Medicine for the Treatment of Vascular Dementia: An Overview of Scientific Evidence vol.2016, pp.1741-4288, 2016, https://doi.org/10.1155/2016/7293626
- Cognitive-Enhancing Herbal Formulae in Korean Medicine: Identification of Candidates by Text Mining and Literature Review vol.22, pp.5, 2016, https://doi.org/10.1089/acm.2015.0257
- Herbal medicine for management of the behavioural and psychological symptoms of dementia (BPSD): A systematic review and meta-analysis vol.31, pp.2, 2017, https://doi.org/10.1177/0269881116675515
- Potential benefits of phytochemicals against Alzheimer's disease vol.76, pp.02, 2017, https://doi.org/10.1017/S0029665116002962
- Neuroprotective effects of a biodegradable poly(lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential nanotherapy for Alzheimer’s disease? pp.1029-2330, 2017, https://doi.org/10.1080/1061186X.2017.1354002
- Ginsenoside Rb1 improves leptin sensitivity in the prefrontal cortex in obese mice pp.17555930, 2018, https://doi.org/10.1111/cns.12776
- Recent Findings in Alzheimer Disease and Nutrition Focusing on Epigenetics vol.7, pp.5, 2016, https://doi.org/10.3945/an.116.012229
- Effects of lifetime cumulative ginseng intake on cognitive function in late life vol.10, pp.1, 2018, https://doi.org/10.1186/s13195-018-0380-0
- Ginseng: A Qualitative Review of Benefits for Palliative Clinicians pp.1938-2715, 2019, https://doi.org/10.1177/1049909118822704
- Cordycepin (3'-deoxyadenosine) attenuates age-related oxidative stress and ameliorates antioxidant capacity in rats vol.47, pp.12, 2011, https://doi.org/10.1016/j.exger.2012.09.003
- Effects of fermented ginseng on memory impairment and β-amyloid reduction in Alzheimer's disease experimental models vol.37, pp.1, 2011, https://doi.org/10.5142/jgr.2013.37.100
- Red ginseng extract protects against carbon tetrachloride-induced liver fibrosis vol.37, pp.1, 2011, https://doi.org/10.5142/jgr.2013.37.45
- Actoprotective effect of ginseng: improving mental and physical performance vol.37, pp.2, 2011, https://doi.org/10.5142/jgr.2013.37.144
- A High-Fat Diet Increases Oxidative Renal Injury and Protein Glycation in D-Galactose-Induced Aging Rats and Its Prevention by Korea Red Ginseng vol.60, pp.3, 2011, https://doi.org/10.3177/jnsv.60.159
- Protective effects of ginseng on neurological disorders vol.7, pp.None, 2011, https://doi.org/10.3389/fnagi.2015.00129
- Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial vol.5, pp.1, 2011, https://doi.org/10.1159/000375295
- 6-Hydroxydopamine으로 유도된 질소적 세포 사멸에 대한 고려홍삼 추출물의 보호효과 vol.60, pp.2, 2011, https://doi.org/10.17480/psk.2016.60.2.92
- 내분비교란물질 비스페놀 A를 처리한 마우스에서 홍삼 추출물의 간 섬유화 개선 vol.30, pp.2, 2011, https://doi.org/10.7732/kjpr.2017.30.2.125
- Panax ginseng as an adjuvant treatment for Alzheimer's disease vol.42, pp.4, 2011, https://doi.org/10.1016/j.jgr.2017.12.008
- Active ginseng components in cognitive impairment: Therapeutic potential and prospects for delivery and clinical study vol.9, pp.71, 2018, https://doi.org/10.18632/oncotarget.26035
- Panax ginseng components and the pathogenesis of Alzheimer's disease vol.19, pp.4, 2011, https://doi.org/10.3892/mmr.2019.9972
- Red Ginseng Attenuates Aβ-Induced Mitochondrial Dysfunction and Aβ-mediated Pathology in an Animal Model of Alzheimer’s Disease vol.20, pp.12, 2019, https://doi.org/10.3390/ijms20123030
- Red Ginseng Inhibits Tau Aggregation and Promotes Tau Dissociation In Vitro vol.2020, pp.None, 2020, https://doi.org/10.1155/2020/7829842
- Efficacy of Panax ginseng Meyer Herbal Preparation HRG80 in Preventing and Mitigating Stress-Induced Failure of Cognitive Functions in Healthy Subjects: A Pilot, Randomized, Double-Blind, Placebo-Co vol.13, pp.4, 2011, https://doi.org/10.3390/ph13040057
- Promising Intervention Approaches to Potentially Resolve Neuroinflammation And Steroid Hormones Alterations in Alzheimer’s Disease and Its Neuropsychiatric Symptoms vol.12, pp.5, 2011, https://doi.org/10.14336/ad.2021.0122
- Immune enhancement effects of Korean ginseng berry polysaccharides on RAW264.7 macrophages through MAPK and NF-κB signalling pathways vol.32, pp.1, 2021, https://doi.org/10.1080/09540105.2021.1934419
- The Application of Seaweed Polysaccharides and Their Derived Products with Potential for the Treatment of Alzheimer’s Disease vol.19, pp.2, 2011, https://doi.org/10.3390/md19020089
- Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer’s disease vol.21, pp.5, 2011, https://doi.org/10.1080/14737175.2021.1906223
- Neuroprotective Natural Products for Alzheimer’s Disease vol.10, pp.6, 2021, https://doi.org/10.3390/cells10061309
- Network Pharmacology of Red Ginseng (Part I): Effects of Ginsenoside Rg5 at Physiological and Sub-Physiological Concentrations vol.14, pp.10, 2011, https://doi.org/10.3390/ph14100999